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transitions in response to ionizing radiation
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aMRC Toxicology Unit, University of Cambridge, Leicester, UK; bBeatson Institute for Cancer Research, Glasgow, UK
ABSTRACT
Common hallmarks of cancer include the dysregulation of cell cycle progression and the acquisi-
tion of genome instability. In tumors, G1 cell cycle checkpoint induction is often lost. This
increases the reliance on a functional G2/M checkpoint to prevent progression through mitosis
with damaged DNA, avoiding the introduction of potentially aberrant genetic alterations.
Treatment of tumors with ionizing radiation (IR) utilizes this dependence on the G2/M checkpoint.
Therefore, identification of factors which regulate this process could yield important biomarkers
for refining this widely used cancer therapy. Leucine zipper and ICAT domain containing (LZIC)
downregulation has been associated with the development of IR-induced tumors. However,
despite LZIC being highly conserved, it has no known molecular function. We demonstrate that
LZIC knockout (KO) cell lines show a dysregulated G2/M cell cycle checkpoint following IR
treatment. In addition, we show that LZIC deficient cells competently activate the G1 and early
G2/M checkpoint but fail to maintain the late G2/M checkpoint after IR exposure. Specifically, this
defect was found to occur downstream of PIKK signaling. The LZIC KO cells demonstrated severe
aneuploidy indicative of genomic instability. In addition, analysis of data from cancer patient
databases uncovered a strong correlation between LZIC expression and poor prognosis in several
cancers. Our findings suggest that LZIC is functionally involved in cellular response to IR, and its
expression level could serve as a biomarker for patient stratification in clinical cancer practice.
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DNA damage can be induced by numerous internal
and external sources, such as the collapse of DNA
replication forks and exposure to exogenous high-
energy radiation [1]. Upon recognition of DNA
damage, cells mount a coordinated response of adap-
tive signaling pathways collectively termed the DNA
damage response (DDR) [2]. In addition to DNA
break repair pathways, the DDR includes a series of
specialized DNA damage sensing and signaling pro-
teins which arrest the cell at specific checkpoints dur-
ing the cell cycle [3]. These checkpoints allow for the
completion of DNA repair prior to DNA replication
and cell division [4]. Importantly, checkpoints will
activate depending on the specific modalities of
damage, for example, activation of the G2/Mitosis
(G2/M) checkpoint is associated with the exposure
of cells to high-energy radiation [5,6]. The break-
down of cell cycle checkpoint control can be
a precursor to multiple pathological conditions, such
as tumorigenesis. Most widely studied is the loss of
p53 and p21 proteins resulting in failure to activate G1
checkpoint [7,8]. In these situations, the G2/M check-
point becomes critically important for the mainte-
nance of cell genome stability [9].
Activation and maintenance of the G2/M check-
point is controlled by protein kinases. The phospha-
tidylinositol 3-kinase-related kinase (PIKK) family is
activated following identification of DNA damage.
Ataxia-telangiectasia mutated (ATM) and Ataxia-
telangiectasia mutated and Rad3 related (ATR) are
members of this family. One function of these pro-
teins following damage is to activate the G2/M check-
point signaling cascade [10]. To maintain the signal
transduction cascade the master regulator of the G2/
M signaling cascade, checkpoint protein 1 kinase
(Chk1), is activated [11]. This requires phosphoryla-
tion of two serine residues at positions 345 (S345) and
317 (S317), which is mediated by ATR and ATM.
Importantly, phosphorylated Chk1 is essential for
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the activation of the G2/M checkpoint in response to
treatment with ionizing radiation (IR) [12]. Chk1
functions by phosphorylating specific inhibitory sites
within cell cycle control proteins. An example of this
is the phosphorylation of WEE1 by Chk1 in response
to damage, which in turn induces an inhibitory phos-
phorylation event on Tyrosine 15 (Tyr15) of CDC2,
inhibiting entry into mitosis [13]. The G2/M check-
point is maintained until DNA repair has been com-
pleted at which point the checkpoint is deactivated
and cells resume normal cell cycle. Release from cell
cycle arrest is conducted by various protein phospha-
tase family members, such as PP2 and PP1. This
activity is through the removal of phosphorylation
from inhibitory sites on cell cycle controllers [14,15].
Incorrect functioning of any step within this process
can lead to a dysfunctional G2/M checkpoint, which
can result in chromosomal abnormalities, e.g., aneu-
ploidy [16]. Cellular reaction to IR encompasses both
direct repair response and induction of checkpoint
signaling cascade. While many proteins which med-
iate these responses have been identified, further
investigation into these response pathways is required
to understand the nuances of control.
One protein, which was linked to cellular IR
response, is the Leucine zipper and ICAT domain
containing (LZIC) protein [17]. LZIC is a putative
member of the WNT signaling family [17]. The
LZIC protein is composed of 190 amino acids (21
kDa) and contains two domains, an N-terminal
coiled-coil and a C-terminal ICAT-like domain
(Supplemental Figure 1A). Unlike ICAT protein,
which antagonizes WNT signaling by binding and
inhibiting ß-catenin, LZIC protein does not interact
withß-catenin [18]. Furthermore, in a ratmodel of IR-
induced osteosarcoma reduced LZIC expression was
associated with the onset of oncogenesis [19–21]. To
investigate the function of LZIC protein we have
employed CRISPR technology to derive LZIC knock-
out (KO) cell lines. Our data show that LZIC is
a component of the cellular response to IR. LZIC
deficient cells show dysregulated transcription after
IR treatment and fail to efficiently maintain the G2/
M checkpoint, with the generation of severe genomic
instability. Finally, analysis of patient databases iden-
tified a positive correlation between LZIC expression
and average patient survival time in a number of
cancers, suggesting that LZIC expression could serve
as a biomarker for patient stratification.
Results
LZIC deletion leads to gene expression changes
following treatment with ionizing radiation
LZIC is a putative member of the WNT signaling
pathway, which typically regulates the activity of
TCF/LEF family transcription factors and has been
implicated in response to IR [22]. As such, we
sought to determine the impact of LZIC loss on
late transcriptional regulation following IR [23].
To address this question, CRISPR was used to
generate an HEK293 cell line with a deletion of
LZIC (LZIC KO Clone 1) and a control line, which
has undergone the CRISPR process, but with no
LZIC deletion (Supplementary Figure 1B).
Differential expression was determined by com-
paring whole genome expression profiling 24
h following 5 Gy of IR with cells which were left
untreated for both LZICKO and the CRISPR control
(Figure 1A). Genes involved in the response to DNA
damage were found to be differentially regulated
following treatment with IR in the CRISPR control
(Figure1, Group A). Following the loss of LZIC
expression, we detected 42 genes which are uniquely
regulated (Figure 1, Group B). To further investigate
the relationship between these groups a z-score ana-
lysis was conducted. This indicates strongly related
clusters of genes between the cell lines, with the
reduced expression of histone subunits being most
conserved following treatment with IR (Figure 1B).
However, differences between the two cell lines can
be observed, with a dysregulation of several long-
non-coding (lnc) RNAs and a downregulation
DHRS2, which is involved in the p53 regulatory
cascade, in LZIC KO conditions.
To directly investigate the loss of LZIC on the
transcriptome, the differential expression between
LZIC KO cells and CRISPR control was determined.
In untreated conditions, we identified a total of 62
unique genes which are differentially regulated fol-
lowing LZIC loss (Figure 1A, Group C). Genes
involved in neuronal development, such as FOXQ1
and Peripherin, are present in line with previous
reports of LZIC function. In comparison, we found
24 unique genes which are differentially regulated in
response to IR following LZIC loss (Figure 1A,
Group D). This group includes genes such as
PLK2, which has a role in cell division. Among the
genes identified following LZIC KO, regardless of



























































































































































































































































































































































































































































































































































































LZIC KO clone 1 vs
   CRISPR Control 
    (IR)
LZIC KO clone 1 vs
   CRISPR Control 
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LZIC KO clone 1
(IR vs no IR)
CRISPR control
(IR vs no IR)
Figure 1. The loss of LZIC expression alters transcriptome under basal conditions and in response to ionizing radiation. (A) Venn diagram
comparing the numbers of genes with significantly altered log-fold changes between LZIC KO clone vs CRISPR control cells in control and IR
conditions. (B) Heatmaps representing Z-scores for genes comparing transcriptomic profiles in CRISPR control to LZIC KO Clone 1 cell lines in
response to 5 Gy IR. (C) Heatmaps representing Z-scores for comparison of transcriptional profiles between CRISPR control and LZIC KO Clone
1 either under basal condition or following IR exposure. (D) Hallmark gene groups analyzed in GSEA and their associated FDR q-value (E)
Barcode plots for significant GSEA hallmark gene groups. Microarray was repeated on two separate biological repeats with two technical
repeats of each condition.
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treatment with IR, were SFN and CCBN1, which are
critical regulators of the G2/M checkpoint (Figure
1C). The 10 most significantly altered transcripts
from each unique group are highlighted in table
form (Supplementary Figure 1C). Differential
expression of 10 mRNAs was validated by qPCR
(Supplementary Figure 2A & 2B).
To examine specific pathways which were dysre-
gulated in LZIC KO we utilized GSEA (Gene set
enrichment analysis) using MSigDB (Molecular
Signatures Database) hallmark gene sets. This
revealed that LZIC KO causes alteration of MYC
signaling and G2/M checkpoint pathways following
treatment with IR (Figure 1D & 1E) [24,25]. This
analysis was also performed on the basal conditions,
identifying MYC targets and E2F targets, suggesting
that MYC alterations are LZIC dependent, with
changes to G2/M and E2F targets being treatment
dependent (Supplementary Figure 2C).
Overall our transcriptome analysis found that
LZIC KO cells had an altered transcriptional pro-
file under both basal conditions and after treat-
ment with IR, with a particular focus on cell cycle
regulation.
LZIC loss leads to increased release from G2/M
phase in response to IR
Our transcriptomic analysis found dysregulation of
mRNA for critical G2/M checkpoint regulatory genes
following treatment with IR in LZIC KO. Altered
abundance of cyclin B1 and SFN, in particular, have
been linked to progression through the G2/M transi-
tion with damaged DNA [26]. Therefore, we used
flow cytometry to assess changes in cell cycle distribu-
tion in LZIC KO cells following IR treatment. The
parental line and an additional LZIC knockout line
(LZIC KO Clone 2) were included in this analysis to
increase the robustness of derived conclusions
(Supplementary Figure 3A & 3B). We observed G2/
M checkpoint induction in all cell lines at 8-h post-IR
(Figure 2A middle panel). Interestingly, when mea-
sured at 24hr post-IR LZIC KO cell lines showed
a significantly reduced G2/M population, with
a concurrent increase of cells present in the G1
phase (Figure 2A bottom panel). This effect was spe-
cific to exposure to IR, since cells treated with camp-
tothecin (CPT), cobalt chloride (CoCl2), or Ultra-
violet light (UV) showed no phenotype
(Supplementary Figure 4A and 4B). To confirm that
altered cell cycle distribution was LZIC KO specific
and not due to off-target effects, a FLAG-tagged LZIC
cDNAwas stably introduced into the LZIC KOClone
2 line. The expression of exogenous LZIC protein was
lower than endogenous levels (Supplementary Figure
2A), despite this, exogenous LZIC partially reversed
the KO phenotype confirming its specificity (Figure
2B). While the data suggests a defective G2/M check-
point, the activation of G1 checkpoint following IR
treatment was assessed. We used phosphorylation of
p53 serine 15 (Ser 15) as a marker of G1 checkpoint
signaling induction as it occurs in response to DNA
damage and promotes association with p53-
responsive promoters [27]. The phosphorylation of
p53 Ser 15 is consistent across all the cell lines indicat-
ing correct induction of G1 checkpoint signaling irre-
spective of LZIC loss (Figure 2C).
Two G2/M checkpoints have been characterized:
a minor immediate (within 1-h post-IR) ATM-
dependent checkpoint and a major ATM-
independent G2 accumulation checkpoint [5]. To
determine whether induction of early G2/M check-
point was perturbed, techniques demonstrated by Xu,
et.al, were utilized [5]. ATM inhibitor-treated cells
were utilized as an experimental control and show
an increase in the mitotic ratio relative to the WT
cells, indicating loss of the ATM-dependent early
checkpoint (Figure 2D). In contrast, the LZIC KO
cell lines show no deviation from the WT at the
time points measured indicating a correct activation
of the early G2/M checkpoint. Finally, the phosphor-
ylation of histone 3 Serine 10 (pS10 H3) occurs upon
entry into late G2 and persists until rapid depho-
sphorylation occurs in early G1 [28]. Quantification
of the pS10 H3 population gives a further measure of
those cells present in late G2 and mitosis. We found
that at 24-h post-IR LZIC KO cells had a reduced
positively stained population (Figure 2E). We con-
clude that LZIC KO cells successfully induce activa-
tion of cell cycle checkpoints but fail to sustain the late
G2/M checkpoint and proceed to mitosis
prematurely.
Defective signaling downstream of Chk1 in LZIC
KO cells
The ATR and ATM kinases are essential for the
establishment of the G2/M checkpoint following
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Figure 2. Late G2/M checkpoint arrest is perturbed following LZIC loss. (A) Cell cycle analysis of cell lines by propidium iodide staining. Cell
lines were treated with 5 Gy IR and following a 24hr incubation harvested for analysis. Graphs are based on four separate biological repeats (B)
Cell cycle analysis of LZIC KO Clone 2 and stable re-expression of LZIC-flag. Graphs based on three separate biological repeats. (C) p53
phosphorylation status in all cell lines, over a 4-h time course, following treatment with IR. A representative blot is shown from three separate
biological repeats. (D) Activation of early G2/M checkpoint induction, following treatment with IR. The inclusion of Parental + ATMi provides
a positive control for loss of early G2/M checkpoint activation. Graphs based on three separate biological repeats. (E) Quantification of
phosphorylated serine 10 on Histone 3. Cells were treated with 2 Gy IR and harvested at 24 h. Images indicate staining profile with arrows to
denote the quantified cells. Graphs based on three separate biological repeats. All statistical significance was determined with unpaired
student T-Test, * = p-value < 0.05, n.s = non-significant. CRISPR control and LZIC KO Clones were compared to the parental line.
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damage induction (Figure 3D) [11]. The activity of
ATR and ATM following treatment with IR is
regulated by phosphorylation on specific activa-
tion residues [29,30]. Analysis of canonical ATR
and ATM activation sites show no impact of LZIC
loss upon phosphorylation following IR treatment
(Figure 3A). The major cell cycle targets of these
kinases are both Chk1 and checkpoint protein 2
(Chk2). While Chk1 is the master regulator of G2/
M, checkpoint interplay with Chk2 has been
observed [31]. Analysis of Chk2 expression levels
and activation showed no deviation between LZIC
KO cells and control lines. In contrast, the phos-
phorylation of Chk1 serine 317 was reduced in the
absence of LZIC (Figure 3B). The phosphorylation
status of Chk1 has a direct impact upon its func-
tion, particularly, serine 317 which can reduce the
activity of the other two major activation sites
serine 296 and serine 345 [12]. Therefore, the
phosphorylation status of downstream compo-
nents reliant on Chk1 activation was analyzed.
The mitosis promoting factor (MPF) is
a complex containing cyclin B1 and CDC2 [32].
Phosphorylation of CDC2 at tyrosine 15, a DNA
damage-induced phosphorylation site, occurs
through a Chk1 mediated pathway and was
reduced in LZIC KO clones [33]. Given interde-
pendence between the MPF components, we
further investigated the status of cyclin B1 in this
condition, as the expression levels of cyclin B1 and
phosphorylation of cytoplasmic to nuclear import
sites directly effect the progression of cells through
mitosis. LZIC KO cells showed reduced expression
levels of cyclin B1 at 8-h and 24-h post-IR.
Furthermore, phosphorylation of cyclin B1 at ser-







Figure 3. Cellular signaling for activation of G2/M checkpoint in response to IR is perturbed in LZIC KO cells. (A) Analysis of ATR and
ATM phosphorylation status at 8 and 24-h post-treatment with 5 Gy IR. (*) indicates protein band corresponding to ATR protein. (B)
Western blot analysis of checkpoint proteins at 8 h and 24 h in all cell types following treatment with 5 Gy IR. (C) Western blot
analysis of Mitosis promoting factors at 8 and 24 h following treatment with 5 Gy IR. (D) Western blot analysis of major G2/M
phosphatases, PP1 and PP2A, at 8 and 24 h following treatment with IR. (E) Schematic diagram of regulatory cascade showing key
proteins involved in the G2/M cell cycle progression and their DNA damage-induced phosphorylation sites. All western blots shown
are representative image of three separate biological repeats.
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aberrant in LZIC KOs with peak phosphorylation
occurring at 8-h post-IR relative to 24 h seen in
control cell lines (Figure 3C) [34]. This data sug-
gests that the MPF complex regulation is altered in
response to IR treatment, following LZIC loss,
facilitating progression through the G2/M check-
point into mitosis.
The phosphorylation status of Chk1 is controlled
by the interplay between the PIKK proteins and
removal of phosphorylation by the protein phospha-
tase family. To assure that LZIC loss did not lead to
loss of phosphatase expression, overall expression of
protein phosphatase 1 (PP1) and protein phosphatase
2 A (PP2A) was conducted. We show that the overall
expression levels of the phosphatases are unchanged
(Figure 3D). We conclude that LZIC operates down-
streamof PIKK signaling and that LZICKOcells show
a selective defect in the execution of IR-induced sig-
naling which converges on the MPF (Figure 3E).
Loss of LZIC leads to genome instability and poor
prognosis for clear renal cell carcinoma
A premature release of cells from the G2/M check-
point increases the chance of chromosome loss and
the development of aneuploidy (Figure 4A) [35]. Cells
were either left untreated or exposed to IR and meta-
phase spreads were used to determine chromosome
numbers. Under basal conditions, LZIC KO cell lines
showed a reduced number of chromosomes when
compared to controls. Similar chromosome loss was
observed in control cells following IR exposure
(Figure 4B). Notably, the genome instability observed
in LZIC cells following IR does not increase beyond
observed levels in the untreated population. Analysis
of cell viability following treatment with IR indicates
an increased sensitivity for LZIC KO, which could
indicate that the population with increased genome
instability are lost (Supplementary Figure 4C). These
data suggest that LZIC KO cell lines had sponta-
neously undergone chromosome loss before IR treat-
ment and that IR-induced instability can generate an
equivalent outcome in control cells.
Next, we analyzed available cancer patient data-
bases of RNA-seq data to determine whether there
was a correlation of LZIC RNA expression levels
with patient prognosis [36]. Although LZIC RNA
expression correlated with poor patient survival for
a range of cancers, the most striking effect was
observed for the clear renal cell carcinoma and
neuroendocrine tumors, in which reduction of
LZIC expression correlated with a severe decrease
in average patient survival times (Figure 4C).
Discussion
A major treatment modality for cancer is IR,
which is used in isolation or in combination with
small molecular inhibitors and chemical che-
motherapy. The identification of biomarkers for
sensitivity to IR is important for improving
response rates to this treatment. LZIC expression
was shown to be specifically downregulated during
the development of IR-initiated oncogenesis [21].
However, the cellular function of LZIC is currently
unknown. This investigation aimed to identify the
role of LZIC within the cell, and more specifically,
the IR response cascade.
This study has generated human LZIC KO cell
lines to investigate the effect of LZIC loss on the
transcriptomic response to IR. From these data, we
can conclude that following IR treatment, LZIC acts
to regulate the cell cycle checkpoint cascade, more
specifically at the G2/M checkpoint. To our knowl-
edge, this is the first study to suggest such a function
for LZIC. In general, the increased activity of WNT
signaling proteins at the G2/M checkpoint, and dur-
ing mitotic spindle assembly, has been widely char-
acterized [37]. One example of which is the interplay
between β-catenin and DNA ligase IV being an
important radioresistance determinant [38].
Therefore, this finding agrees with current roles for
WNT signaling proteins. In addition, WNT signaling
is an important pathway during oncogenesis, with
the identification of altered LZIC regulation having
been established in multiple cancers [19–21]. The
hypothesis presented here suggests reduced LZIC
expression is linked to induced oncogenesis by
decreased checkpoint control.
The transcriptomic analysis of LZIC KO cells iden-
tified altered MYC signaling in untreated and treated
conditions. This suggested that the altered regulation
of this pathway is not IR specific and is, instead,
a direct response to the loss of LZIC. The regulation
of MYC signaling by WNT pathway proteins, for
example, the upregulation of c-myc by β-catenin,
can promote cell proliferation and differentiation
[39,40]. Further investigation would be required to
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determine a role for LZIC in the regulation of the
MYC pathway. However, these data suggest a similar
role to canonical WNT signaling components.
The analysis of pS10 H3 levels in LZIC KO cells
following IR identified a reduced number of cells
in late G2 and mitosis compared to control lines.
(a) (b)
Renal Clear Cell Carcinoma Neuroendocrine tumour
(c)
Figure 4. Loss of LZIC leads to genome instability and poor prognosis in clear cell renal carcinoma. (A) Schematic outlining the
development of aneuploidy following loss of G2/M checkpoint control. (B) Metaphase spread quantification of chromosome numbers
from Parental, CRISPR control line, and LZIC KO Clone 1 and 2. Data from 3 biological repeats counting at least 17 spreads per
replicate. Statistical significance was determined using unpaired student T-Test, *** = p-value < 0.001, n.s = non-significant. CRISPR
control and LZIC KO clones were compared to the parental line in the untreated condition. (C) Kaplan Meier plot showing overall
survival of patients stratified by LZIC expression. The calculated hazard ratios and significance is also included.
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Previous literature shows that following release
from the G2/M checkpoint, the mitotic population
significantly increases [5]. However, the release
from the G2/M checkpoint can begin as early as
12-h post-IR [5]. In this case, we hypothesize that
LZIC KO cells undergo early G2/M checkpoint
release prior to the 24-h time point, which causes
the majority of the population to have passed
through mitosis into G1. In G1 the mitotic pS10
H3 is rapidly lost, decreasing the observable popu-
lation. These data are supported by the cell cycle
analysis at 24 h indicating an increased G1 popu-
lation (Figure 2A).
The phosphorylation of Chk1 S317 is mediated
by ATR. The loss of this phosphorylation event has
been shown to perturb the function of surrounding
phosphorylation sites S345 and S296 [12].
Therefore, the reduced phosphorylation of this
site in LZIC KO cells could have a detrimental
impact on Chk1 activity. Interestingly, the altered
phosphorylation status of the MPF components is
downstream of both Chk1 and the protein phos-
phatase family [41]. We hypothesize that while
expression levels of PP1 and PP2 are not altered, it
is the interplay between these proteins and Chk1
which leads to the defect of checkpoint control.
The genome instability observed in LZIC KO
cells is significant under basal conditions. The link
between a dysfunctional G2/M checkpoint and
increased genome instability has been previously
shown [35]. In addition, a damage threshold must
be overcome to successfully activate the spindle
assembly checkpoint [42]. LZIC KO cells do not
show changes to cell cycle prior to damage with
IR; however, it is possible that LZIC cells possess
a defect which increases the number of cells pro-
gressing through cell cycle with damage. We sti-
pulate that LZIC cells reduce the fidelity of the G2/
M checkpoint, which over time will yield the phe-
notypes of genome instability.
Following LZIC KO the transcriptional signa-
tures identified showed altered regulation of multi-
ple genes with known functions in neuronal
differentiation and development. A previous
study has identified LZIC as a factor required for
the correct development of the zebrafish brain
midline [18]. The high conservation of LZIC in
zebrafish and the interaction with genes associated
with the development may provide a basis for
further investigation into the regulation of these
pathways, leading to a mechanism by which this
process is controlled.
Collectively our data classifies LZIC as function-
ally involved in the IR response cascade. Clearly
more mechanistic data on LZIC protein and its
interacting factors are necessary to fully compre-
hend the contribution of this protein to mamma-
lian DDR. However, even at this early stage, our
data are suggestive of the usefulness of LZIC as
a biomarker for patient stratification, given that its
expression is strongly correlated with survival of
patients suffering from clear cell renal carcinoma.
Materials and methods
LZIC protein evolutionary conservation analysis
National center for bioinformatics information
(NCBI) nucleotide sequence database was interro-
gated manually and the nucleotide sequences for
Human, Mouse, Xenopus, Zebrafish, Nematodes,
and Slimemold were acquired. The previously
identified domains were aligned, by ClustalW
[43], and a percentage conservation score calcu-
lated by assessing the number of nucleotides con-
served between sequences by the equation – total
number of conserved nucleotides (Analyzed spe-
cies)/total number of nucleotides (Humans).
Cell culture
HEK293 were cultured at 5% CO2 in
Dulbecco’s-modified Eagle’s medium (DMEM),
supplemented with 4.5 g/l D-glucose, GlutaMAX
(Life Technologies, Carlsbad, CA, USA) and 10%
fetal bovine serum.
LZIC knock-out line generation
LZIC-targeting CRISPR-based knockout plasmid kit
was purchased from Origene. HEK293 cells were
transfected with plasmids provided in Origene kit
using Lipofectamine LTX. Cells were cultured for
eight passages before addition of antibiotic selection,
as per manufacturer’s instructions. Cells were
reseeded and treated with Puromycin (0.5μg/ml)
and individual colonies were selected, by the use of
cloning discs. Individual colonies were expanded and
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screened for LZIC expression by western blot. LZIC-
Flag CDS was reintroduced into LZIC knockout (KO)
Clone 2 by Lentiviral transduction. Prior to transduc-
tion LZIC KO clone 2 was transfected with Cre
recombinase plasmid to remove puromycin resistance
cassette from a cell line.
Microarray analysis of LZIC KO cells
All clones were plated in duplicate for both untreated
and IR treated conditions. After 24 h, cells were
exposed to 5 Gy IR and incubated for a further 24
h before harvesting. Untreated cells were harvested
48-h post seeding. Cells were harvested using trypsin
and EDTA before RNA extraction using RNeasy kit
(Qiagen) as per manufacturers instructions. Samples
were subsequently labeled by low input quick amp
labeling (Agilent Technologies) as per manufac-
turer’s instructions in one-colour microarray-based
gene expression analysis. The chipset reference was
G4858A, GE 8 x 60K with design 039494 V3. 100 ng
of RNA was used for analysis. Microarray was
imaged on DNA microarray scanner with Surescan
high-resolution imaging (Agilent technologies). The
resulting raw data were analyzed using the R package
Limma as conducted in previous studies [44,45].
Gene set enrichment analysis (GSEA) was conducted
by comparing gene sets to the Molecular Signatures
Database (MSigDB) [24].
qPCR analysis
HEK293 cells and LZIC KO clones were grown for 24
h prior to treatment with 5 Gy IR. Cells were har-
vested by trypsinization prior to extraction of RNA
using RNeasy kit (Qiagen kit). 1000 ng of extracted
RNAwas reverse transcribed to cDNA by Superscript
II (Thermo Fisher Scientific) as per the manufac-
turer’s instructions. The qPCR was conducted using
SYBR green reagent (Applied Biosystems,
Thermofisher) and plates were analyzed on
Quantstudio 6 flex (Applied Biotechnologies). Delta-
delta ct calculation was conducted using GAPDH as
a reference gene. Primers sequences used are shown
in Table 1.
Western blotting
HEK293 and CRISPR lines were seeded and 24
h following either left untreated or exposed to 5Gy
IR. The cells were then harvested at the stated time
points following IR. Cells extracts were generated by
the addition of RIPA buffer (150mM NaCl, 50nM
Tris pH 7.5, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% SDS, 1mM DTT, 0,4mM PMSF,
Protease inhibitor cocktail) and sonication for 2 × 10
s. Samples were loaded with 1x Laemmli buffer before
being heated to 90°C for 10min. Samples were run on
SDS-Page gels and transferred to nitrocellulose mem-
brane by use of Bio-Rad Transblot Turbo. The anti-
bodies used were: LZIC (Bethyl, 1/1000), Tubulin
(Sigma Aldrich, 1/5000), pChk2 Thr68 (Cell signal-
ling, 1/2000), Chk2 total (Bethyl, 1/2000), pChk1 S345
(Bethyl, 1/2000), pChk1 S317 (Bethyl, 1/2000), Chk1
total (Bethyl, 1/2000), pATR Tyr1981 (Cell signalling,
1/1000), ATR total (Cell signalling, 1/1000), pCyclin
B1 Ser147 (Cell signalling, 1/2000), Cyclin B1 (Cell
signalling, 1/2000), pCDC2 Tyr15 (Cell signalling, 1/
2000), and CDC2 total (Cell signalling, 1/2000).
Secondary goat antibody was horseradish peroxidase
Table 1. Primer sequences for qPCR.
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conjugated with reactivity against mouse or rabbit
(Thermo Fischer Scientific). All further antibodies
were analyzed using LICOR system using goat-
secondary with conjugated fluorescence. PP2A – sub-
unit A (Cell signalling, 1/1000), PP2A – subunit
B (Cell signalling, 1/1000), PP2A – subunit C (Cell
signalling, 1/1000), PP1 (Santa Cruz, 1/1000), pATM
Serine 1981 (Cell signalling, 1/1000), ATM total (Cell
signalling, 1/1000), Vinculin (Abcam, 1/5000), p53
total (Santa Cruz, 1/1000), p-p53 Serine 15 (Cell sig-
nalling, 1/1000).
Cell cycle analysis
Twenty-four hours after seeding HEK293 cells and
CRISPR clones were treated with IR (5 Gy), camp-
tothecin (20 μM), cobalt chloride (200 μM), or UV
(20 mJ) and incubated 24 h. Cells were incubated
for further 8 and 24 h and then harvested. After
washing with PBS, ice-cold 70% ethanol was
slowly added under slight agitation. Cells were
left at 4°C for 24 h to fix, PBS washed, and
Propidium Iodide and RNase A were added to
final concentration of 10ug/ml and 100ug/ml,
respectively. Samples were heated to 37°C for 30
min and then incubated at 4°C for at least 4
h before reading. Flow cytometry analysis of cells
was conducted on a BD biosciences FACS canto.
Early G2/M checkpoint activation
This method was conducted as shown in Xu, et.al.
2002 [5]. One set of control cells were additionally
treated with ATMi (10μM final concentration,
Sigma Aldrich) 1 h prior to exposure to 5 Gy IR.
Cells were stained with pS10 H3 antibody (Cell
Signalling, 1/100) and incubated with Goat-anti-
rabbit 488 (Abcam, 1/500). The cells were then
analyzed on Attune NXT (Life Technologies).
Immunofluorescence
Parental HEK293 and CRISPR clones were seeded
and treated with 2 Gy IR. The cells were incubated
for 24 h before supernatant was removed and cells
washed with PBS. Four percent Paraformaldehyde
was used to fix cells for 10 min at room tempera-
ture before treatment with blocking buffer (0.3%
triton X-100 in PBS supplemented with 5% goat
serum). Fixed cells were treated with primary anti-
body overnight at 4°c. Cells were washed 3x with
PBS before the addition of secondary antibody and
incubated at room temperature for 1 h. Cells were
mounted with hard set mounting medium (vector
hard set mounting medium, Vector labs). Images
were acquired using a Zeiss LSM 510 and images
were processed with ZEN 2009 software. Primary
antibody – Phospho-serine 10 Histone 3 antibody
(Cell Signalling Technology, 1/1000). Secondary
antibody was goat anti-rabbit with conjugated
Cy5 (Thermo Fischer Scientific).
Metaphase spread analysis
Parental HEK293 and CRISPR clones were seeded
and treated with 2 Gy IR before incubating for 48
h. Cells were harvested by trypsinization and cen-
trifuged at 300 g 5 min before swelling buffer
(75 mM KCl) was added. The cell pellet was incu-
bated for 10 min at room temperature before
addition of a fixative solution (Methanol and
acetic acid 3:1 ratio). The Cells were centrifuged
at 200 g for 5 min and the supernatant was
removed. This step was repeated twice. Pellet was
suspended in fixative to give cell suspension and
dropped from a height of 30 cm onto slides
(Superfrost plus, Thermo scientific). Slides were
dried at room temperature for 2 min before steam-
ing for 10 s. Slides were left in a humidity box
overnight to dry. Cells were stained with Dapi (1/
5000) diluted in PBS and then mounted. Images
were acquired using a Zeiss LSM 510. Manual
counts were conducted of spreads to determine
chromosomal numbers.
Cell viability assay
Cells were treated with 0, 40, 60, or 80 Gy IR before
a 24-h incubation. The WST-1 reagent (Sigma
Aldrich) was used and data analyzed as per manufac-
turers instructions. With the following deviations, the
WST-1 reagent was added 2 h prior to absorbance
quantification. With the absorbance being read by
Powerwave XS2 plate reader (BioTek).
Kaplan-meier plot generation
The PROGgene V2 database was used to generate
Kaplan-Meier plots for LZIC expression in cancers
[36]. The overall survival of patients was analyzed
with no stratification apart from LZIC expression.
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